Teladoc Health Files 8-K on Shareholder Votes

Ticker: TDOC · Form: 8-K · Filed: 2024-05-24T00:00:00.000Z

Sentiment: neutral

Topics: shareholder-vote, corporate-governance, filing

Related Tickers: TDOC

TL;DR

TDOC filed an 8-K for shareholder votes - nothing specific yet, but they're voting on stuff.

AI Summary

Teladoc Health, Inc. filed an 8-K on May 23, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or resolutions presented, but it confirms the company's adherence to reporting requirements for such events.

Why It Matters

This filing indicates that Teladoc Health held a shareholder meeting where important corporate decisions were put to a vote, a standard but necessary disclosure for public companies.

Risk Assessment

Risk Level: low — The filing is a routine procedural disclosure and does not contain any new financial or operational information that would immediately impact the company's risk profile.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Teladoc Health's security holders?

The provided 8-K filing does not specify the exact matters submitted for a vote. It only states that such matters were presented.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 23, 2024.

What is Teladoc Health, Inc.'s state of incorporation?

Teladoc Health, Inc. is incorporated in Delaware.

What is the principal executive office address for Teladoc Health, Inc.?

The principal executive office address is 2 Manhattanville Road Suite 203 Purchase, NY 10577.

What is the Commission File Number for Teladoc Health, Inc.?

The Commission File Number for Teladoc Health, Inc. is 001-37477.

From the Filing

0001477449-24-000122.txt : 20240524 0001477449-24-000122.hdr.sgml : 20240524 20240524162516 ACCESSION NUMBER: 0001477449-24-000122 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240523 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240524 DATE AS OF CHANGE: 20240524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 24984773 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 8-K 1 tdoc-20240523.htm 8-K tdoc-20240523 FALSE 0001477449 0001477449 2024-05-23 2024-05-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 23, 2024 ___________________________________ Teladoc Health, Inc. (Exact name of registrant as specified in its charter) ___________________________________ Delaware (State or other jurisdiction of incorporation) 001-37477 (Commission File Number) 04-3705970 (I.R.S. Employer Identification No.) 2 Manhattanville Road Suite 203 Purchase , NY 10577 (Address of principal executive offices and zip code) ( 203 ) 635-2002 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common stock, par value $0.001 per share TDOC The New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.07     Submission of Matters to a Vote of Security Holders. The 2024 Annual Meeting of Stockholders (the “Annual Meeting”) of Teladoc Health, Inc. (the “Company”) was held on May 23, 2024. The Company previously filed with the Securities and Exchange Commission a definitive proxy statement and related materials pertaining to the Annual Meeting, which describe in detail each of the four proposals submitted to stockholders at the Annual Meeting. The final results for the votes regarding each proposal are set forth below. Proposal 1 — Election of Directors The stockholders of the Company elected each

View on Read The Filing